Triumph Research Intelligence (TRI), a leading provider of Risk Based Monitoring (RBM) solutions for clinical trials, has completed a deal with Octopus Investments, assisted by members of Simons Muirhead Burton’s Corporate, Commercial and Finance team.
TRI’s remit to improve data reliability, increase patient safety and operational efficiency, and save the industry millions of pounds each year, is helped by the deal which will accelerate TRI’s core technology platform, OPRA, and expand its international presence. TRI was founded by CEO Duncan Hall in 2013 and developed the first dedicated cloud-based software for RBM. It is currently based in the UK in Cambridge, and in the USA in Raleigh, North Carolina.
Of SMB, Duncan Hall has said:
“Going through the process of raising funds through a venture capital trust for the first time is a complex and challenging process. It was as much about knowing the right questions as it was about having the right answers. SMB guided us through the legal side of the process, covering both the big picture and the granular detail…. They were able to provide support across a wide range of legal disciplines, bringing in the right advisors as and when needed. They have become a trusted partner during the course of the process and we will continue to use them as our business grows.”
Octopus Investments, part of Octopus Group, is an award-winning, fast-growing UK fund management business and are experts in smaller companies, renewable energy, and healthcare infrastructure.
In a judgment handed down on Tuesday 19th January, SMB won a claim to recover the domain name blackjack.com on behalf of our client, Hanger Holdings.Read more
SMB’s Music department has launched a partnership with The BRIT School, the UK’s first and leading free performing and creative arts school, who are responsible… Read more
SMB’s Media Team have advised FAE Film and Television Limited on the production and financing of new film Save The Cinema for Sky Cinema.Read more